Anika Therapeutics, Inc.
ANIK
$21.23
$0.552.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.78M | -7.09M | -6.91M | -29.07M | -26.74M |
| Total Depreciation and Amortization | 5.63M | 4.13M | 4.31M | 4.43M | 3.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.22M | 15.53M | 10.96M | 31.18M | 27.80M |
| Change in Net Operating Assets | -15.10M | -5.91M | 3.01M | 1.78M | -2.63M |
| Cash from Operations | 5.98M | 6.47M | 11.19M | 8.13M | 6.28M |
| Capital Expenditure | -5.42M | -3.97M | -5.36M | -6.02M | -4.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 4.50M | 4.50M | 4.50M |
| Other Investing Activities | 1.36M | 1.19M | 1.00M | 155.00K | 0.00 |
| Cash from Investing | -4.05M | -3.31M | -401.00K | -1.91M | -1.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 449.00K | 239.00K | 239.00K | 297.00K | 297.00K |
| Repurchase of Common Stock | -16.79M | -15.88M | -10.97M | -11.10M | -11.09M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -16.34M | -15.46M | -10.55M | -10.63M | -14.60M |
| Foreign Exchange rate Adjustments | -339.00K | -396.00K | -259.00K | -324.00K | -22.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.76M | -12.35M | 322.00K | -4.38M | -9.66M |